July 19, 2024
Macrophage Marker Market

Rapid Urbanization to Boost Growth of the Global Macrophage Marker Market

The global Macrophage Marker Market is estimated to be valued at US$ 256.2 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Macrophage markers are used to identify and study macrophages, a type of white blood cell, in tissues and cell culture systems. Macrophages play a vital role in innate immunity by engulfing and digesting foreign particles and microbes. They are involved in inflammation, wound healing, and maintenance of tissue homeostasis. Common macrophage markers include CD11b, CD14, CD68, CD163, etc. Their expression helps distinguish macrophages from other immune cells. With growing use of macrophage markers in diagnostic and research applications, the market is poised to experience substantial growth over the coming years.

Market key trends:

One of the key trends in the macrophage marker market is the increasing prevalence of inflammatory and autoimmune diseases globally. Since macrophages are major players in inflammation, the demand for macrophage markers is rising from biotechnology and pharmaceutical companies engaged in researching new therapeutic targets and drugs for conditions such as rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, etc. Furthermore, rapid urbanization in developing nations has led to greater exposure to toxins and foreign antigens, contributing to the incidence of inflammatory disorders. This is expected to propel the macrophage marker market during the forecast period.

Porter’s Analysis

Threat of new entrants: The macrophage marker market requires high capital investments in R&D which makes the threat of new entrants low. Bargaining power of buyers: The bargaining power of buyers is moderate due to the presence of alternative options for macrophage marker detection. Bargaining power of suppliers: The bargaining power of suppliers is low due to availability of substitute raw materials suppliers. Threat of new substitutes: The threat of new substitutes is moderate as researchers are constantly developing new techniques for macrophage detection which can substitute the existing markers. Competitive rivalry: The competitive rivalry is high among the key players to gain higher market share.

Key Takeaways

The Global Macrophage Marker Market Size is expected to witness high growth, exhibiting CAGR of 6.5% over the forecast period, due to increasing R&D investments in cancer immunotherapy.

Regional analysis
North America is expected to dominate the global macrophage marker market during the forecast period. This is attributed to the presence of well-established healthcare sector and major market players in the region. Asia Pacific region is anticipated to exhibit the fastest growth rate owing to rising geriatric population, increasing healthcare spending, and growing investments in cell-based research.

Key players
Key players operating in the macrophage marker market are Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., BD Biosciences, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., BioLegend, Inc., Merck KGaA, Novus Biologicals, LLC, R&D Systems, Inc. (a Bio-Techne brand), Santa Cruz Biotechnology, Inc., Beckman Coulter, Inc., Miltenyi Biotec GmbH, GeneTex, Inc., MBL International Corporation.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it